| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1056/NEJM199612123352407 |
| P698 | PubMed publication ID | 8943165 |
| P2093 | author name string | Ginsberg JS | |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1816-1828 | |
| P577 | publication date | 1996-12-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Management of venous thromboembolism | |
| P478 | volume | 335 |
| Q39450705 | A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws |
| Q31939613 | A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators. |
| Q34381941 | Accuracy of single-detector spiral CT in the diagnosis of pulmonary embolism: a prospective multicenter cohort study of consecutive patients with abnormal perfusion scintigraphy |
| Q53752130 | Acute pulmonary thromboembolism in emergency room: gray-scale versus color doppler ultrasound evaluation. |
| Q34746681 | Adherence to guidelines for oral anticoagulation after venous thrombosis and pulmonary embolism |
| Q73262237 | Anti-beta2-glycoprotein I antibodies in patients with acute venous thromboembolism: prevalence and association with recurrent thromboembolism |
| Q24244696 | Anticoagulants versus non-steroidal anti-inflammatories or placebo for treatment of venous thromboembolism |
| Q35936298 | Anticoagulation therapy for venous thromboembolism. |
| Q77901248 | Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosis |
| Q73111224 | Application of likelihood ratios to clinical decision rules: defining the limits of clinical expertise |
| Q33338711 | Bleeding and thrombotic complications in critically ill patients with cancer |
| Q33441723 | Bullous hemorrhagic dermatosis due to enoxaparin use in a bullous pemphigoid patient |
| Q46906665 | Comparable pharmacokinetics and pharmacodynamics of melagatran in Japanese and caucasian volunteers after oral administration of the direct thrombin inhibitor ximelagatran |
| Q53337125 | Comparative effectiveness of general practitioner versus pharmacist dosing of patients requiring anticoagulation in the community. |
| Q44852505 | Comparison of 1 month with 3 months of anticoagulation for a first episode of venous thromboembolism associated with a transient risk factor |
| Q33183711 | Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study |
| Q33917883 | Comparison of long versus short duration of anticoagulant therapy after a first episode of venous thromboembolism: a meta-analysis of randomized, controlled trials |
| Q42756997 | Compression ultrasonography for diagnosing deep vein thrombosis. One examination of whole leg is better than two of selected parts |
| Q41620890 | Controversies in the use of lower extremity sonography in the diagnosis of acute deep vein thrombosis and a proposal for a unified approach |
| Q41245830 | Cost-effectiveness of low-molecular-weight heparin in the treatment of proximal deep vein thrombosis |
| Q35104528 | Critical care in orthopedic and spine surgery |
| Q40883424 | Current concepts of anticoagulant therapy in pregnancy |
| Q32084744 | Current data on the treatment of venous thromboembolic disease |
| Q53330691 | Deep Vein Thrombosis. |
| Q73522231 | Deep vein thrombosis |
| Q42005892 | Deep vein thrombosis: diagnosis of a comon clinical problem. |
| Q49433564 | Delayed retroperitoneal arterial hemorrhage after inferior vena cava filter deployment: A case report |
| Q33759045 | Diagnostic approach to patients with suspected pulmonary embolism: a report from the real world |
| Q39799215 | Differential interactions of heparin and heparan sulfate glycosaminoglycans with the selectins. Implications for the use of unfractionated and low molecular weight heparins as therapeutic agents |
| Q38477068 | Early discharge strategies following venous thrombosis |
| Q73635494 | Effects of Intravenous Enoxaparin and Intravenous Inogatran in an Electrolytic Injury Model of Venous Thrombosis in the Dog |
| Q33147159 | Emergency department management of pulmonary embolism |
| Q51574539 | Evaluation of a chromogenic assay to measure the factor Xa inhibitory activity of unfractionated heparin in canine plasma. |
| Q47876111 | Evaluation of a new, rapid, and quantitative D-Dimer test in patients with suspected pulmonary embolism |
| Q73861677 | Failure of low dosage thrombolytic therapy with streptokinase to treat heparin-induced thrombocytopenic-thrombotic syndrome |
| Q24630993 | Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis |
| Q42114560 | Heparin blocks transfer of extracellular vesicles between donor and recipient cells |
| Q36254845 | Hypercoagulable states and stroke: a selective review. |
| Q35149161 | Innovations in total knee replacement: new trends in operative treatment and changes in peri-operative management |
| Q36960618 | Ins and outs of inferior vena cava filters in patients with venous thromboembolism: the experience at Monash Medical Centre and review of the published reports |
| Q44690701 | Low-molecular-weight heparin versus saphenofemoral disconnection for the treatment of above-knee greater saphenous thrombophlebitis: a prospective study |
| Q41703407 | Major bleeding after hospitalization for deep-venous thrombosis. |
| Q34215816 | Management of oral anticoagulants in the treatment of venous thromboembolism |
| Q52072604 | Management of patients with suspected deep vein thrombosis in the emergency department: combining use of a clinical diagnosis model with D-dimer testing. |
| Q82093193 | Management of pregnant women with prosthetic heart valves |
| Q34227288 | Management of venous thromboembolic disease in the chronically critically ill patient |
| Q33349065 | Management of venous thromboembolism during pregnancy |
| Q45035898 | Management patterns and outcomes of patients with venous thromboembolism in the usual community practice setting |
| Q81351789 | Medical complications after stroke |
| Q96303282 | Micellization-induced amplified fluorescence response for highly sensitive detection of heparin in serum |
| Q55023794 | Molecular and Clinical Issues about the Risk of Venous Thromboembolism in Older Patients: A Focus on Parkinson's Disease and Parkinsonism. |
| Q73491064 | Mortality, hospital discharges, and case fatality for pulmonary embolism in the Twin Cities: 1980-1995 |
| Q45306740 | No effect of encapsulation on the pharmacokinetics of warfarin |
| Q39456098 | Noninvasive venous testing in the diagnosis of pulmonary embolism: the impact on decisionmaking |
| Q58034475 | Nonmalignant portal vein thrombosis in adults |
| Q44029837 | Outpatient management of DVT using low molecular weight heparin and a hospital outreach service |
| Q37586922 | Patterns of anticoagulation following bioprosthetic valve implantation: observations from ANSWER |
| Q46906661 | Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran in young healthy Japanese men. |
| Q73068650 | Plasma D-dimer testing improves the management of thromboembolic disease in hospitalized patients |
| Q48019926 | Prediction of hemorrhagic and thrombotic events in patients with mechanical heart valve prostheses treated with oral anticoagulants. |
| Q50147294 | Prevalence of preterminal pulmonary thromboembolism among patients on maintenance hemodialysis treatment before and after introduction of recombinant erythropoietin |
| Q33919309 | Prophylactic anticoagulation to prevent venous thromboembolism in traumatic intracranial hemorrhage: a decision analysis |
| Q92916671 | Rapid assembly and profiling of an anticoagulant sulfoprotein library |
| Q39879015 | Recurrent Venous Thromboembolism in Two Patients With Cancer Taking Rivaroxaban |
| Q73291623 | Recurrent venous thromboembolism in a Spanish population: incidence, risk factors, and management in a hospital setting |
| Q36030487 | Risk factors of recurrent venous thromboembolism: the role of residual vein thrombosis |
| Q48311158 | Specific enrichment combined with highly efficient solid-phase tagging for the sensitive detection of heparin based on boronic acid-functionalized mesoporous silica nanospheres. |
| Q44820370 | The pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor, are unaffected by a single dose of alcohol |
| Q73669943 | The radiological investigation of suspected lower limb deep vein thrombosis |
| Q50867078 | The role of the nonspecific inflammatory markers in determining the anatomic extent of venous thromboembolism. |
| Q41194751 | The role of thoracic ultrasonography in the diagnosis of pulmonary embolism |
| Q52533632 | Therapeutic inhibition of thrombin activities, receptors, and production. |
| Q77579610 | Thrombin-antithrombin III complex in acute retinal vein occlusion |
| Q78007700 | Thrombosis in pregnancy |
| Q40868158 | Treatment of venous thrombo-embolism |
| Q35977663 | Treatment of venous thromboembolism and long-term prevention of recurrence: present treatment options and ximelagatran |
| Q43702751 | Treatment of venous thromboembolism using only low-molecular-weight heparin? |
| Q33987051 | Tumor-related thrombotic pulmonary microangiopathy: review of pathologic findings and pathophysiologic mechanisms |
| Q77352967 | Two instruments to determine activated partial thromboplastin time: implications for heparin monitoring |
| Q36286443 | Update on the diagnosis and management of pulmonary embolism. |
| Q47390135 | Use of a modified dosing weight for heparin therapy in a morbidly obese patient |
| Q43290035 | Use of subcutaneous lepirudin in an obese surgical intensive care unit patient with heparin resistance |
| Q46759742 | Valvular heart disease in pregnancy. A contemporary perspective |
| Q34341225 | Venous thromboembolism and pregnancy |
| Q35753482 | Ximelagatran: the first oral direct thrombin inhibitor |
| Q75183797 | Young patients with iliofemoral deep venous thrombosis should receive thrombolytic therapy |
| Q77499582 | [Duration of oral anticoagulant therapy in venous thromboembolism] |
| Q77369143 | [Fibrinolytic therapy of deep vein thrombosis] |
| Q73869700 | [Value and limitations of pulmonary scintigraphy/venous duplex Doppler echography in the management of pulmonary embolism] |
Search more.